{"id":"https://openalex.org/W44768776","doi":null,"title":"Response of MHC class-1 antigen on rat glioma cells to cytokines.","display_name":"Response of MHC class-1 antigen on rat glioma cells to cytokines.","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W44768776","mag":"44768776","pmid":"https://pubmed.ncbi.nlm.nih.gov/10769703"},"language":"en","primary_location":{"id":"pmid:10769703","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10769703","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111363743","display_name":"Shinya Oshiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31784960","display_name":"Fukuoka University","ror":"https://ror.org/04nt8b154","country_code":"JP","type":"education","lineage":["https://openalex.org/I31784960"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S Oshiro","raw_affiliation_strings":["Department of Neurosurgery, School of Medicine, Fukuoka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, School of Medicine, Fukuoka University, Japan","institution_ids":["https://openalex.org/I31784960"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T Fukushima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Fukushima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110841703","display_name":"Masamichi Tomonaga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Tomonaga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019253871","display_name":"Keith L. Black","orcid":"https://orcid.org/0000-0002-0546-4934","observed_orcids":["https://orcid.org/0000-0002-0546-4934"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K L Black","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2262,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.48534954,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"1C","first_page":"605","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5303000211715698,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5303000211715698,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.421099990606308,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03189999982714653,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mhc-class-i-antigens","display_name":"MHC class I antigens","score":0.9269999861717224},{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.8240000009536743},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.7319999933242798},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8999999761581421},{"id":"https://openalex.org/keywords/il-4","display_name":"IL-4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9070000052452087},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.6980000138282776},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.7975131273269653},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.6659634113311768},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.6552427411079407},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6421357989311218},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6024510860443115},{"id":"https://openalex.org/C2778814158","wikidata":"https://www.wikidata.org/wiki/Q959350","display_name":"MHC class II","level":4,"score":0.5570015907287598},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5122410655021667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4917450249195099},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.44554275274276733},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.43829160928726196},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42709219455718994},{"id":"https://openalex.org/C119997001","wikidata":"https://www.wikidata.org/wiki/Q21113110","display_name":"CD74","level":5,"score":0.42050987482070923},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23963788151741028},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.046385616064071655},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0379507839679718}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005910","descriptor_name":"Glioma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10769703","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10769703","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:44768776","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10769703","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1980146494","https://openalex.org/W1983098040","https://openalex.org/W2042423862","https://openalex.org/W2034581531","https://openalex.org/W1753359669","https://openalex.org/W2418097950","https://openalex.org/W329343584","https://openalex.org/W1974421192","https://openalex.org/W2606572020","https://openalex.org/W2024812826"],"abstract_inverted_index":{"BACKGROUND:":[0],"Enhanced":[1],"MHC":[2,31,64,80,113,133],"class-1":[3,32,65,81,114,134],"expression":[4,33,62,96,115,135],"has":[5],"potentially":[6],"been":[7],"correlated":[8],"with":[9,91,121],"the":[10,24,51,61,95,104,110],"increased":[11,94],"susceptibility":[12],"of":[13,27,54,63,79,97,103],"tumor":[14],"cells":[15],"to":[16,148],"a":[17],"T":[18],"cell-mediated":[19],"immune":[20],"response.":[21],"We":[22],"examined":[23],"immunomodulatory":[25,52],"effects":[26,53],"some":[28],"cytokines":[29,55],"on":[30,60],"in":[34,85,100,127,136,154],"rat":[35,44,105,137],"glioma":[36,45,87,106,138],"cell":[37,46,88,107],"lines.":[38,108],"MATERIALS":[39],"AND":[40],"METHODS:":[41],"Using":[42],"three":[43,102],"lines":[47],"(RG2,":[48],"C6,":[49],"9L),":[50],"(rhIL-2,":[56],"rmIL-4,":[57],"rmGM-CSF,":[58,125],"rrIFN-gamma)":[59],"antigen":[66,82,99],"were":[67,83],"evaluated":[68],"using":[69],"immunohistochemical":[70],"and":[71],"flow":[72],"cytometric":[73],"analyses.":[74],"RESULTS:":[75],"Varying":[76],"baseline":[77],"levels":[78],"confirmed":[84],"each":[86],"line.":[89],"Stimulation":[90],"rrIFN-gamma":[92,130,144],"consistently":[93],"MHC-1":[98],"all":[101],"On":[109],"other":[111],"hand,":[112],"was":[116],"not":[117],"affected":[118],"by":[119],"stimulation":[120],"rhIL-2,":[122],"rmIL-4":[123],"or":[124],"even":[126],"combination.":[128],"CONCLUSIONS:":[129],"can":[131],"upregulate":[132],"cells.":[139],"Our":[140],"data":[141],"suggest":[142],"that":[143],"may":[145],"be":[146],"able":[147],"exert":[149],"antitumor":[150],"activity":[151],"against":[152],"gliomas":[153],"vivo.":[155]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}